Prakt. lékáren. 2009; 5(3): 114-117

New recommendations for the treatment of arterial hypertension

MUDr. Filip Málek, Ph.D., MBA
3. lékařská fakulta Univerzity Karlovy, Praha

During past decades pharmacotherapy of arterial hypertension underwent significant development. New guidelines for the management

of arterial hypertension defined several categories according to the blood pressure levels and blood pressure therapy goals too.

Pharmacotherapy of hypertension is guided either by blood pressure level, or the presence of associated clinical condition, the severity

of target organ damage and the total cardiovascular risk. The efficacy of the treatment on cardiovascular mortality and morbidity is based

on the effect on blood pressure lowering. Effective decrease of blood pressure is provided by: thiazide diuretics, beta-blockers, calcium

channel blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. These drugs represent the treatment

of choice either for monotherapy, or for the combination. Choice of the treatment drug group depends on the type of the associated

clinical condition.

Keywords: arterial hypertension, pharmacotherapy, guidelines, target values, cardiovascular risk.

Published: May 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Málek F. New recommendations for the treatment of arterial hypertension. Pharmacy for Practice. 2009;5(3):114-117.
Download citation

References

  1. Vasan R, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682-1686. Go to original source... Go to PubMed...
  2. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovasclar Disease Prevention in Clinical Practice. Eur Heart J 2007; 28: 2375-2414.
  3. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension 2007; 25: 1105-1187. Go to original source... Go to PubMed...
  4. Widimský J, Cífková R, Špinar K, et al. Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2007. Cor Vasa 2008; 50(1): Kardio K3-K16.
  5. Conroy R, Pyörälä K, Fitzgerald AP, et al. SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003. Go to original source... Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.